FDA greenlights Pfizer booster shot for certain groups; CDC advisory panel votes to recommend boosters

Sep 23, 2021 - 02:57 PM
FDA Gives Full Approval to Pfizer-BioNTech COVID-19 Vaccine. COVID-19 vaccine bottles, syringes, and COVID-19 cells.

The Food and Drug Administration late last night amended Pfizer’s emergency use authorization for its COVID-19 vaccine to allow for an additional, booster dose for certain individuals. FDA will authorize a booster shot to be administered six months following a completed two-dose regiment for the following:

  • individuals 65 years of age and older; 
  • individuals in the 18-64 age range who are at high risk of severe COVID-19; and
  • individuals in the 18-64 age range whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19, including severe disease.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today advanced the possibility of booster shots, voting unanimously to recommend boosters for the 65-and-older age group and people in long-term care facilities. ACIP also fully recommended giving a single booster dose to people between the ages of 50 and 64 with certain high risk conditions.

The ACIP meeting was continuing at the time of AHA Today’s publication, with the committee discussing occupational exposure issues that may warrant a booster. AHA tomorrow will update members on this issue.

Related News Articles

Headline
CDC recommends two doses of COVID-19 vaccine for older individuals, lowers pneumococcal vaccine age 
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
CMS releases final guidance on hospital respiratory data condition of participation reporting requirements 
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
FDA authorizes combination tests for flu, COVID-19
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
CDC: COVID-19 surging across the U.S.
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
CDC issues advisory on increased parvovirus B19 cases in the U.S. 
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
CDC encourages older adults to get additional COVID-19 vaccine dose 
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…